Search results
17 cze 2022 · Patients with cancer frequently receive immune-checkpoint inhibitors (ICIs), which may modulate immune responses to COVID-19 vaccines. Recently, cytokine release syndrome (CRS) was...
23 lut 2024 · One study examining blood samples from severe COVID-19 patients upon recovery observed elevated erythrocyte sedimentation rates, increased levels of C-reactive protein (CRP), and reduced...
24 kwi 2019 · Sensitivities for cancer were 46.1% for CRP, 43.6% ESR and 49.7% for PV. Cancer should be considered in patients with raised inflammatory markers.
18 maj 2020 · For the patients stratified by severity of COVID-19, random-effect results demonstrated that compared with patients in the severe group, patients in the nonsevere group had lower levels for CRP (WMD = −41.78 mg/l, 95% CI = −52.43, −31.13], P < 0.001), PCT (WMD = −0.13 ng/ml, 95% CI = [−0.20, −0.05], P < 0.001), IL-6 (WMD = −21.32 ...
Compared with recovered COVID patients, long COVID patients showed higher levels of IL-6 (6 of 20, 30%), CRP (3 of 20, 15%), and TNF-α (3 of 20, 15%); lower levels of hemoglobin (2 of 20, 10%). Notably, cytokine/chemokine and biochemical markers accounted for 23.9% (11 of 46) and 39.1% (18 of 46), respectively.
15 sty 2021 · Elevated serum levels of C-reactive protein (CRP), a marker of systemic inflammation, are associated with severe disease in bacterial or viral infections. We aimed to explore associations between CRP concentration at initial hospital presentation and clinical outcomes in patients with COVID-19.
C-reactive protein (CRP) has been used inconsistently both in patient management and as a prognostic marker during COVID-19. Admission elevated CRP for patients with COVID-19 was associated with increased inpatient mortality and was indicative of disease severity at admission.
